MERREM Side Effects

6816890-9 | Hepatic Failure
on Jun 25, 2010 Male patient from ITALY , 66 years of age, was diagnosed with abdominal abscess and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic failure. Merrem dosage: . During the same period patient was treated with CLEXANE T (View Clexane T Review and Clexane T Label ), LASIX (View Lasix Review and Lasix Label ), LUVION (View Luvion Review and Luvion Label ), CREON (View Creon Review and Creon Label ), MAG 2 (View Mag 2 Review and Mag 2 Label ), METOCAL (View Metocal Review and Metocal Label ), KCL RETARD (View Kcl Retard Review and Kcl Retard Label ). Patient was hospitalized.

6701810-8 | Accidental Overdose
Patient was taking Merrem (View Usage). Patient had the following side effects: accidental overdose on Apr 20, 2010 from CANADA Additional patient health information: Male patient , weighting 170.0 lb, . Merrem dosage: .

6600733-2 | Neutropenia
Adverse event was reported on Feb 23, 2010 by a Male patient taking Merrem (View Usage) (Dosage: 2 Grams Every 8 Hours Iv Drip) was diagnosed with brain abscess and. Location: UNITED STATES , weighting 208.9 lb, After Merrem was administered, patient had the following side effects: neutropenia. During the same period patient was treated with KEPPRA (500 Mg Every 12 Hours Po) (View Keppra Review and Keppra Label ). Patient was hospitalized.

6590232-9 | Bronchospasm
on Feb 11, 2010 Female patient from ITALY , 85 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm. Merrem dosage: .


6558024-4 | Eosinophil Count Increased
on Jan 27, 2010 Female patient from UNITED STATES , 22 years of age, weighting 136.0 lb, was diagnosed with chronic sinusitis and was treated with Merrem (View Usage). Patient had the following side effects: eosinophil count increased. Merrem dosage: 2 Grams Every 8 Hours Intravenous Bolus. During the same period patient was treated with ALBUTEROL SULFATE NEBULIZING SOLUTION (View Albuterol Sulfate Nebulizing Solution Review and Albuterol Sulfate Nebulizing Solution Label ), ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), ALLEGRA (View Allegra Review and Allegra Label ), HEPARIN FLUSH (PORCINE) IN NS IV (View Heparin Flush (porcine) In Ns Iv Review and Heparin Flush (porcine) In Ns Iv Label ), LIDOCAINE PRILOCAINE (EMLA) (View Lidocaine-prilocaine (emla) Review and Lidocaine-prilocaine (emla) Label ), LIPASE PROTEASE AMYLASE (PANCREASE MT) (View Lipase-protease-amylase (pancrease Mt) Review and Lipase-protease-amylase (pancrease Mt) Label ).

6547035-0 | Dermatitis Bullous, Liver Disorder, Skin Reaction
Patient was taking Merrem (View Usage). After Merrem was administered, patient had the following side effects: dermatitis bullous, liver disorder, skin reaction on Jan 15, 2010 from ITALY Additional patient health information: Male patient , 13 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Merrem dosage: . During the same period patient was treated with VANCOMICINA AP (View Vancomicina Ap Review and Vancomicina Ap Label ), RIFADIN (View Rifadin Review and Rifadin Label ). Patient was hospitalized.

6542359-5 | Eosinophil Count Increased
Adverse event was reported on Jan 14, 2010 by a Female patient taking Merrem (View Usage) (Dosage: 2 Grams Every 8 Hours Iv Bolus) was diagnosed with chronic sinusitis, cystic fibrosis and. Location: UNITED STATES , 22 years of age, weighting 136.0 lb, Patient experienced the following unwanted or unexpected effects: eosinophil count increased. During the same period patient was treated with ALBUTEROL SULFATE AUTOHALER (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), COLISTIMETHATE SODIUM (View Colistimethate Sodium Review and Colistimethate Sodium Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), ALLEGRA (View Allegra Review and Allegra Label ), HEPARIN FLUSH PORCINE IN NS IV (View Heparin Flush -porcine- In Ns Iv Review and Heparin Flush -porcine- In Ns Iv Label ).

6493014-1 | Rash Maculo-papular
on Dec 03, 2009 Female patient from ITALY , 41 years of age, was diagnosed with encephalitic infection, epilepsy (What is epilepsy?), fungal skin infection, thrombosis prophylaxis, cerebral oedema management and was treated with Merrem (View Usage). Patient had the following side effects: rash maculo-papular. Merrem dosage: . During the same period patient was treated with AURANTIN (View Aurantin Review and Aurantin Label ), VANCOMICINA HOSPIRA (View Vancomicina Hospira Review and Vancomicina Hospira Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), CLEXANE (View Clexane Review and Clexane Label ), DEFLAMON (View Deflamon Review and Deflamon Label ), DESAMETASONE FOSFATO HOSPIRA (View Desametasone Fosfato Hospira Review and Desametasone Fosfato Hospira Label ). Patient was hospitalized.

6428050-4 | Convulsion
on Oct 30, 2009 Male patient from CANADA , 55 years of age, weighting 165.3 lb, was diagnosed with infection (What is infection?), convulsion and was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: convulsion. Merrem dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), KEPPRA (View Keppra Review and Keppra Label ).

6408944-6 | Tooth Discolouration
Patient was taking Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: tooth discolouration on Aug 06, 2009 from UNITED STATES Additional patient health information: Male patient , 13 years of age, . Merrem dosage: .

6408940-9 | Product Quality Issue, Pruritus, Urticaria
Adverse event was reported on Oct 08, 2008 by a Female patient taking Merrem (View Usage) (Dosage: 2 Gm/100cc) was diagnosed with infection (What is infection?) and. Location: UNITED STATES , 23 years of age, Patient had the following side effects: product quality issue, pruritus, urticaria. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), JANUVIA (View Januvia Review and Januvia Label ), ULTRASE MT20 (View Ultrase Mt20 Review and Ultrase Mt20 Label ).

6408938-0 | Convulsion
on Apr 02, 2009 Male patient from UNITED STATES , 15 years of age, was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: convulsion. Merrem dosage: .

6389466-8 | Atonic Seizures
on Sep 25, 2009 Male patient from CANADA , 55 years of age, weighting 165.3 lb, was diagnosed with infection (What is infection?), convulsion and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: atonic seizures. Merrem dosage: . During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), KEPPRA (View Keppra Review and Keppra Label ).

6291870-3 | Eosinophilia, Pyrexia, Rash, Tubulointerstitial Nephritis
Patient was taking Merrem (View Usage). Patient had the following side effects: eosinophilia, pyrexia, rash (What is rash?), tubulointerstitial nephritis on Jul 24, 2009 from UNITED STATES Additional patient health information: Male patient , 15 years of age, weighting 145.5 lb, was diagnosed with brain abscess and. Merrem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), KEPPRA (View Keppra Review and Keppra Label ).

6272301-6 | Accidental Overdose
Adverse event was reported on Jul 10, 2009 by a Male patient taking Merrem (View Usage) (Dosage: ) was diagnosed with pyelonephritis and. Location: UNITED STATES , weighting 5.95 lb, After Merrem was administered, patient had the following side effects: accidental overdose. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6073764-1 | Neutropenia, Pyrexia
on Feb 09, 2009 Female patient from UNITED STATES , child 11 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, pyrexia. Merrem dosage: Intravenous;500.0.

6048675-8 | Convulsion, Depressed Level Of Consciousness, Grand Mal Convulsion
on Jan 15, 2009 Male patient from CANADA , 37 years of age, weighting 176.4 lb, was treated with Merrem (View Usage). Patient had the following side effects: convulsion, depressed level of consciousness, grand mal convulsion. Merrem dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CALCIUM (View Calcium Review and Calcium Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), FERROUS GLUCONATE (View Ferrous Gluconate Review and Ferrous Gluconate Label ), HEPARIN (View Heparin Review and Heparin Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6048674-6 | Hypersensitivity, Pruritus, Pyrexia, Rash, Rash Erythematous, Urticaria
Patient was taking Merrem (View Usage). After Merrem was administered, patient had the following side effects: hypersensitivity, pruritus, pyrexia, rash (What is rash?), rash erythematous, urticaria on Jan 15, 2009 from CANADA Additional patient health information: Male patient , 15 years of age, weighting 101.4 lb, . Merrem dosage: . During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), CLOXACILLIN (View Cloxacillin Review and Cloxacillin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), BACTRIM (View Bactrim Review and Bactrim Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ), CHOLECALCIFEROL (View Cholecalciferol Review and Cholecalciferol Label ). Patient was hospitalized.

5927766-3 | Convulsion
Adverse event was reported on Apr 24, 2008 by a Male patient taking Merrem (View Usage) (Dosage: ) was diagnosed with peritonitis, sepsis (What is sepsis?) and. Location: UNITED STATES , 73 years of age, Patient experienced the following unwanted or unexpected effects: convulsion. During the same period patient was treated with LEVO (View Levo Review and Levo Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

5927761-4 | Chills, Diarrhoea, Nausea, Pain, Pyrexia, Rash Macular
on May 08, 2008 Female patient from UNITED STATES , 19 years of age, was diagnosed with bronchitis (What is bronchitis?), lung infection, cystic fibrosis, pancreatic insufficiency, asthma (What is asthma?) and was treated with Merrem (View Usage). Patient had the following side effects: chills, diarrhoea, nausea (What is nausea?), pain (What is pain?), pyrexia, rash macular. Merrem dosage: . During the same period patient was treated with ULTRASE MT20 (View Ultrase Mt20 Review and Ultrase Mt20 Label ), PULMOZYME (2.5 Mg (1 In 1 D)) (View Pulmozyme Review and Pulmozyme Label ), ALBUTEROL (4 Other (2 Other, 2 In 1 D)) (View Albuterol Review and Albuterol Label ), FLOVENT (110 -4 Other ( 2 Other, 2 In 1 D)) (View Flovent Review and Flovent Label ). Patient was hospitalized.

5927760-2 | Haematocrit Decreased
on Feb 13, 2008 Female patient from UNITED STATES , child 4 years of age, was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: haematocrit decreased. Merrem dosage: . During the same period patient was treated with CEFEPIME (View Cefepime Review and Cefepime Label ).

5927759-6 | Rash, Skin Exfoliation
Patient was taking Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), skin exfoliation on Nov 05, 2007 from UNITED STATES Additional patient health information: Female patient , 81 years of age, . Merrem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

5927758-4 | Disorientation, Hypervigilance
Adverse event was reported on Oct 22, 2007 by a Male patient taking Merrem (View Usage) (Dosage: ) was diagnosed with liver abscess and. Location: UNITED STATES , 55 years of age, weighting 173.9 lb, Patient had the following side effects: disorientation, hypervigilance. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), FLAGYL (View Flagyl Review and Flagyl Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

5927757-2 | Ill-defined Disorder
on Sep 17, 2007 Male patient from UNITED STATES , 70 years of age, was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: ill-defined disorder. Merrem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

5927756-0 | Convulsion
on Sep 12, 2007 Male patient from UNITED STATES , 43 years of age, was diagnosed with abscess (What is abscess?), abdominal abscess and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Merrem dosage: .

5901620-5 | Dermatitis Bullous
Patient was taking Merrem (View Usage). Patient had the following side effects: dermatitis bullous on Sep 26, 2008 from UNITED STATES Additional patient health information: Male patient , 78 years of age, was diagnosed with infection (What is infection?) and. Merrem dosage: 1 Gm Every 8 Hours Iv. Patient was hospitalized.

5833089-3 | Complex Partial Seizures
Adverse event was reported on Jul 31, 2008 by a Male patient taking Merrem (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), sepsis (What is sepsis?) and. Location: UNITED STATES , 58 years of age, weighting 167.6 lb, After Merrem was administered, patient had the following side effects: complex partial seizures. During the same period patient was treated with LINEZOLID (View Linezolid Review and Linezolid Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

5798284-0 | Choking, Constipation, Dyspnoea, Eye Disorder, Gastric Ulcer, Mechanical Ventilation, Tremor
on Jun 26, 2008 Female patient from UNITED STATES , 79 years of age, weighting 155.0 lb, was diagnosed with infection (What is infection?) and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: choking (What is choking?), constipation (What is constipation?), dyspnoea, eye disorder, gastric ulcer, mechanical ventilation, tremor. Merrem dosage: 1 G/ 100 Ml.

5711277-4 | Convulsion
on Apr 18, 2008 Male patient from UNITED STATES , 49 years of age, weighting 235.0 lb, was diagnosed with pneumonia aspiration and was treated with Merrem (View Usage). Patient had the following side effects: convulsion. Merrem dosage: 1 Gram Every 8 Hours Iv. During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

5690560-5 | Tooth Discolouration
Patient was taking Merrem (View Usage). After Merrem was administered, patient had the following side effects: tooth discolouration on Mar 31, 2008 from UNITED STATES Additional patient health information: Female patient , 45 years of age, weighting 132.0 lb, was diagnosed with osteomyelitis and. Merrem dosage: 1 Gram Every 8 Hours Iv. During the same period patient was treated with CEFEPIME (View Cefepime Review and Cefepime Label ), ERTAPENEM (View Ertapenem Review and Ertapenem Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

5489766-X | Tooth Discolouration
Adverse event was reported on Jun 26, 2007 by a Female patient taking Merrem (View Usage) (Dosage: ) was diagnosed with osteomyelitis and. Location: UNITED STATES , child 11 years of age, weighting 95.90 lb, Patient experienced the following unwanted or unexpected effects: tooth discolouration.

5489763-4 | Tongue Discolouration, Tooth Discolouration
on Feb 27, 2007 Male patient from UNITED STATES , 15 years of age, weighting 154.1 lb, was diagnosed with brain abscess and was treated with Merrem (View Usage). Patient had the following side effects: tongue discolouration, tooth discolouration. Merrem dosage: . During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

5489762-2 | Convulsion
on Mar 16, 2007 Female patient from UNITED STATES , 25 years of age, was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: convulsion. Merrem dosage: .

5489757-9 | Agranulocytosis, Neutropenia
Patient was taking Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, neutropenia on Nov 27, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 205.5 lb, was diagnosed with cholangitis, peritonitis, pain (What is pain?), gastrooesophageal reflux disease, contraception and. Merrem dosage: . During the same period patient was treated with DARVOCET (5/325 Daily) (View Darvocet Review and Darvocet Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), BIRTH CONTROL PILLS (View Birth Control Pills Review and Birth Control Pills Label ).

5489754-3 | Convulsion, Electrolyte Imbalance
Adverse event was reported on Aug 28, 2006 by a Male patient taking Merrem (View Usage) (Dosage: ) was diagnosed with nosocomial infection and. Location: UNITED STATES , 46 years of age, Patient had the following side effects: convulsion, electrolyte imbalance. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ).

5479343-9 | Actinic Keratosis
on Oct 04, 2007 Male patient from UNITED STATES , 37 years of age, weighting 181.4 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: actinic keratosis. Merrem dosage: . During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (View Lasix Review and Lasix Label ), ZONEGRAN (View Zonegran Review and Zonegran Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), REGLAN (View Reglan Review and Reglan Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

5476927-9 | Skin Lesion
on Sep 26, 2007 Male patient from ITALY , 36 years of age, was diagnosed with sepsis (What is sepsis?), bacterial sepsis and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: skin lesion. Merrem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICINA (View Gentamicina Review and Gentamicina Label ). Patient was hospitalized.

5444570-3 | Skin Lesion
Patient was taking Merrem (View Usage). Patient had the following side effects: skin lesion on Aug 31, 2007 from ITALY Additional patient health information: Male patient , 36 years of age, was diagnosed with sepsis (What is sepsis?), bacterial sepsis and. Merrem dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICINA (View Gentamicina Review and Gentamicina Label ). Patient was hospitalized.

5273529-4 | Loss Of Consciousness, Nausea
Adverse event was reported on Mar 14, 2007 by a Female patient taking Merrem (View Usage) (Dosage: ) was diagnosed with central nervous system abscess and. Location: UNITED STATES , 42 years of age, weighting 165.3 lb, After Merrem was administered, patient had the following side effects: loss of consciousness, nausea (What is nausea?). During the same period patient was treated with VANCOMYCIN (Level Dependant) (View Vancomycin Review and Vancomycin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

5228043-9 | Hepatitis
on Feb 22, 2006 Male patient from UNITED STATES , 72 years of age, weighting 138.0 lb, was diagnosed with respiratory tract infection and was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). Merrem dosage: 1 G Q12h Iv. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALLEGRA (View Allegra Review and Allegra Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FLOMAX (View Flomax Review and Flomax Label ).

5228042-7 | Convulsion, Electrolyte Imbalance
on Aug 28, 2006 Male patient from UNITED STATES , 46 years of age, was diagnosed with nosocomial infection and was treated with Merrem (View Usage). Patient had the following side effects: convulsion, electrolyte imbalance. Merrem dosage: 2 G Q8h Iv. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ).

5228040-3 | Apnoea, Bradycardia
Patient was taking Merrem (View Usage). After Merrem was administered, patient had the following side effects: apnoea, bradycardia on Jan 19, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 3.75 lb, was diagnosed with blood culture positive, enterobacter infection, sputum culture positive and. Merrem dosage: 20 Mg/kg Q8h Iv. During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), TIMENTIN (View Timentin Review and Timentin Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), ZANTAC (View Zantac Review and Zantac Label ).

5195536-2 | Agnosia, Deafness
Adverse event was reported on Dec 21, 2006 by a Female patient taking Merrem (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?), convulsion and. Location: CANADA , 39 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: agnosia, deafness. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ).

5175632-6 | Agnosia, Deafness
on Nov 27, 2006 Female patient from CANADA , 39 years of age, weighting 143.3 lb, was diagnosed with pneumonia (What is pneumonia?), urinary tract infection (What is urinary tract infection?), convulsion and was treated with Merrem (View Usage). Patient had the following side effects: agnosia, deafness. Merrem dosage: . During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

5171136-5 | Eosinophil Count Increased, Neutropenia
on Dec 06, 2006 Female patient from UNITED STATES , weighting 176.4 lb, was diagnosed with abdominal abscess and was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: eosinophil count increased, neutropenia. Merrem dosage: 1gm Q8h Iv. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BETOPTIC (View Betoptic Review and Betoptic Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), LANTUS, NOVOLOG (View Lantus, Novolog Review and Lantus, Novolog Label ). Patient was hospitalized.

5167072-0 | Agnosia, Deafness
Patient was taking Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: agnosia, deafness on Nov 27, 2006 from CANADA Additional patient health information: Female patient , 39 years of age, weighting 143.3 lb, was diagnosed with pneumonia (What is pneumonia?), convulsion and. Merrem dosage: . During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

5146087-2 | Hypersensitivity, Hypoaesthesia, Paraesthesia, Pruritus, Throat Irritation
Adverse event was reported on Nov 01, 2006 by a Female patient taking Merrem (View Usage) (Dosage: Three Daily) . Location: CANADA , 64 years of age, Patient had the following side effects: hypersensitivity, hypoaesthesia, paraesthesia, pruritus, throat irritation. During the same period patient was treated with CEFTAZIDIME (Three Daily) (View Ceftazidime Review and Ceftazidime Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PANCREASE MT 16 (View Pancrease Mt 16 Review and Pancrease Mt 16 Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ).

5145936-1 | Dermatitis Exfoliative, Rash
on Nov 01, 2006 Male patient from CANADA , 48 years of age, was treated with Merrem (View Usage). After Merrem was administered, patient had the following side effects: dermatitis exfoliative, rash (What is rash?). Merrem dosage: . During the same period patient was treated with ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), AMPICILLIN SODIUM (View Ampicillin Sodium Review and Ampicillin Sodium Label ), CANCIDAS (View Cancidas Review and Cancidas Label ), HEPARIN (View Heparin Review and Heparin Label ), HUMULIN 70/30 (View Humulin 70/30 Review and Humulin 70/30 Label ), HYDROCORTISONE SODIUM (View Hydrocortisone Sodium Review and Hydrocortisone Sodium Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

5145931-2 | Face Oedema, Pruritus, Rash Maculo-papular, Skin Exfoliation
on Nov 01, 2006 Female patient from CANADA , 46 years of age, was treated with Merrem (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, pruritus, rash maculo-papular, skin exfoliation. Merrem dosage: . During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMSA PD (View Amsa Pd Review and Amsa Pd Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ).

5136080-8 | Blood Pressure Increased, Dyspnoea, Fatigue, Hepatic Enzyme Abnormal, Restlessness, Tremor
Patient was taking Merrem (View Usage). Patient had the following side effects: blood pressure increased, dyspnoea, fatigue, hepatic enzyme abnormal, restlessness, tremor on Oct 20, 2006 from BRAZIL Additional patient health information: Male patient , 66 years of age, weighting 167.6 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), hypertension, prostate examination abnormal, sedation and. Merrem dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SECOTEX (View Secotex Review and Secotex Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.